title: [Inflammatory cardiomyopathy: state-of-the-art].
abstract: Cardiomyopathy (CMP) is a major cause of early disability and death in young cardiac patients, remaining at the same time a little studied problem. The generally accepted term "dilated cardiomyopathy" is only a portrayal of morphological signs. As of now, the foreign literature most commonly uses the term "inflammatory cardiomyopathy" to denote CMP caused by viral and/or bacterial agents. Owing to the wide use of novel laboratory and instrumental diagnostic techniques, namely: molecular genetic and immunohistochemical studies and endomyocardial biopsy, there has been a possibility to conduct a more accurate and fuller study of inflammatory CMP. Despite the fact that the problems in nosology, classification, choice of the optimal diagnostic methods and management tactics for these patients.
authors.forename: E A
authors.initials: EA
authors.lastname: Beliavskiĭ
authors.forename: K A
authors.initials: KA
authors.lastname: Zykov
authors.forename: O Iu
authors.initials: OIu
authors.lastname: Narusov
authors.forename: V P
authors.initials: VP
authors.lastname: Masenko
authors.forename: A A
authors.initials: AA
authors.lastname: Skvortsov
authors.forename: A Iu
authors.initials: AIu
authors.lastname: Shchedrina
authors.forename: S N
authors.initials: SN
authors.lastname: Tereshchenko
mesh_terms: D002311:Cardiomyopathy, Dilated / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D002986:Clinical Trials as Topic; D006321:Heart / Q000382:microbiology / Q000821:virology; D006801:Humans; D009205:Myocarditis / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D016896:Treatment Outcome